Literature DB >> 2833752

Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.

A Vafai1, M Wellish, D H Gilden.   

Abstract

Postherpetic neuralgia (PHN), the most frequent complication of varicella-zoster virus (VZV) reactivation, is characterized by pain that persists for greater than 1 mo and often for years after zoster rash. To examine whether PHN might be related to reactivation of VZV, blood mononuclear cells of patients with PHN were tested for the presence of VZV DNA and proteins. VZV DNA was detected in the mononuclear cells of one PHN patient. VZV-specific proteins were detected in mononuclear cells of two acute-varicella patients, one acute zoster patient, and six elderly patients with PHN, but these VZV-specific proteins were not detected in three elderly zoster patients without PHN. Furthermore, pulse-chase experiments revealed further processing or degradation of VZV-specific proteins in the mononuclear cells. These findings strongly suggest that persistence, reactivation, and expression of VZV may result in PHN.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833752      PMCID: PMC280080          DOI: 10.1073/pnas.85.8.2767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia.

Authors:  D H Gilden; Y Rozenman; R Murray; M Devlin; A Vafai
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells.

Authors:  A Sette; S Buus; S Colon; J A Smith; C Miles; H M Grey
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

5.  Pathogenesis of post-herpetic neuralgia.

Authors:  F Schon; M L Mayer; J S Kelly
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

6.  Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3.

Authors:  A Vafai; Z Wroblewska; M Wellish; M Green; D Gilden
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Varicella-zoster virus infection of human mononuclear cells.

Authors:  D H Gilden; A R Hayward; J Krupp; M Hunter-Laszlo; J C Huff; A Vafai
Journal:  Virus Res       Date:  1987-04       Impact factor: 3.303

9.  Polypeptides encoded by varicella-zoster virus unique short sequences.

Authors:  A Vafai; M Wellish; D Gilden
Journal:  Virus Res       Date:  1986-07       Impact factor: 3.303

10.  Affinity-purified varicella-zoster virus glycoprotein gp1/gp3 stimulates the production of neutralizing antibody.

Authors:  Z Wroblewska; D Gilden; M Green; M Devlin; A Vafai
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

View more
  21 in total

1.  Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors:  B Forghani; G J Yu; J W Hurst
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence.

Authors:  M D de Jong; J F Weel; T Schuurman; P M Wertheim-van Dillen; R Boom
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 4.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 5.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

6.  Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster.

Authors:  D H Gilden; M Devlin; M Wellish; R Mahalingham; C Huff; A Hayward; A Vafai
Journal:  Virus Genes       Date:  1989-08       Impact factor: 2.332

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

8.  Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.

Authors:  Donald H Gilden; Randall J Cohrs; Anthony R Hayward; Mary Wellish; Ravi Mahalingam
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

Review 9.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

10.  The challenging patient with varicella-zoster virus disease.

Authors:  Maria A Nagel; Don Gilden
Journal:  Neurol Clin Pract       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.